Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence and Correlates of Synthetic Cannabinoid Use in a Substance Use Treatment Population: An Electronic Health Record Study in Brazil.

Substance use & misuse·2026
Same author

Latent Heterogeneity in Depressive Symptoms, Suicidal Thoughts and Behaviors Among Brazilian Medical Students: Prevalence, Associated Factors, and Group Differences.

Trends in psychiatry and psychotherapy·2026
Same author

The unity and diversity of executive functions across adulthood in a diverse Brazilian sample with varying educational attainment.

Neuropsychology·2026
Same author

Learning Environment, Academic Stressors, and Institutional Aspects as Determinants of Mental Health Outcomes in Medical Education.

Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)·2026
Same author

Transcultural headache medicine: A framework for integrating cultural contexts into headache science and care - a call to action from the International Headache Society.

Cephalalgia : an international journal of headache·2026
Same author

Further insights in the relationship between religiosity and telomere length.

Journal of psychosomatic research·2026

Related Experiment Video

Updated: Jun 22, 2026

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Association between the DRD2-141C Insertion/Deletion polymorphism and schizophrenia.

Quirino Cordeiro1, Jacqueline Siqueira-Roberto, Stevin Zung

  • 1Department of Psychiatry, University of São Paulo Medical School, SP, Brazil. qcordeiro@yahoo.com

Arquivos De Neuro-Psiquiatria
|June 24, 2009
PubMed
Summary

Genetic factors influence schizophrenia risk. This study found a significant association between the dopamine receptor D2 (DRD2) gene

More Related Videos

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

Related Experiment Videos

Last Updated: Jun 22, 2026

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

Area of Science:

  • Neuroscience
  • Genetics
  • Psychiatry

Background:

  • Schizophrenia (SCZ) has a significant genetic component, making genes of the dopaminergic system a focus of molecular research.
  • Antipsychotic medications, particularly first-generation drugs, target the brain's dopaminergic system, highlighting its relevance in schizophrenia treatment and pathogenesis.

Purpose of the Study:

  • To investigate the potential association between the -141 Ins/Del (rs1799732) polymorphism in the dopamine receptor type 2 (DRD2) gene and schizophrenia.
  • To explore the role of specific DRD2 gene variants in the genetic susceptibility to schizophrenia.

Main Methods:

  • A case-control study design was employed.
  • Genotyping of the -141 Ins/Del polymorphism (rs1799732) in the DRD2 gene was performed.
  • Allele and genotype distributions were compared between 229 schizophrenia patients and 733 healthy controls.

Main Results:

  • Significant statistical differences were observed in both allelic (chi2=9.78; p=0.001) and genotypic (chi2=12.74; p=0.001) distributions between schizophrenia patients and controls.
  • The 'Ins' allele of the -141C Ins/Del polymorphism in the DRD2 gene was found to be significantly associated with the schizophrenia phenotype.

Conclusions:

  • The -141C Ins/Del polymorphism of the DRD2 gene, specifically the 'Ins' allele, is associated with an increased risk for schizophrenia in the studied population.
  • These findings contribute to understanding the genetic underpinnings of schizophrenia and the dopaminergic system's role.